Published on in Vol 27 (2025)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/65615, first published
.

Journals
- Nguyen-Hoang N, Nazzal M, Schneider B, Trivedi M, Hertz D. Review of the contribution of clinical and genetic factors to the racial disparity in taxane-induced peripheral neuropathy. Critical Reviews in Oncology/Hematology 2025;211:104739 View
- Gilchrist L, Kocian A, Carroll G, Sturm K, Castro-Pearson S, Cooper C, Radomski M. Screening for Chemotherapy-Induced Peripheral Neuropathy and Instability with a Phone-Based Application: A Pilot Feasibility Study. Rehabilitation Oncology 2025;43(4):173 View
- Lefaucheur J. Screening and monitoring of diabetic polyneuropathy in clinical practice: present and future with connected devices. Frontiers in Neurology 2025;16 View
- Jun Y, Tao X, Choi J, Kidwell K, Hertz D. Effect of Chemotherapy-Induced Peripheral Neuropathy Symptom Permanence on Patient's Preference to Alter or Continue Neurotoxic Chemotherapy Treatment. JCO Oncology Advances 2025;(2) View
